SERUM ISOFORM [-2]PROPSA DERIVATES (%P2PSA AND PHI) SIGNIFICANTLY IMPROVES THE PREDICTION OF PROSTATE CANCER AT INITIAL BIOPSY IN A TPSA RANGE 2-10 NG/ML. A MULTICENTRIC EUROPEAN STUDY